Serum Phosphate, Serum Calcium and Serum iPTH Levels in Patients with CKD and Risk of Cardiovascular events
WIJAN LAL1, SYED HIDAYAT ALI2, AYESHA EJAZ3 , ALIYA JAFRI4, MUHAMMAD ALI5, BILAL AHEED6, HAFIZ ALI, SHABBIR RAJPUT7, LARAIB SHABBIR RAJPUT8, AMNA KHAN9, SHAMAS GHAZANFAR10, KIRAN ABBAS11
1501
ABSTRACTObjective:
To determine the association between serum
phosphorus, serum calcium, and serum iPTH and the occurrence of cardiovascular
events in patients with diagnosed chronic kidney disease.
Methodology:
A prospective cohort study was conducted at
Pir Abdul Qadir Shah Jeelani Institute Of Medical Sciences Gambat, Khairpur
Mirs and Jinnah Postgraduate Medical Centre between August 2019 and July 2020.
All patients over 18 years of age were eligible to participate in the study.
Patients with incomplete data or those who were lost to follow-up were excluded
from the study. Mineral metabolism parameters including, serum calcium,
Phosphorus, and intact iPTH (iPTH), levels were recorded for all patients.
Patients were followed up till the start of August 2020 to record any
cardiovascular event. Patients were sub stratified into two groups i.e. with or
without a CV event.
Results:
The study reported that with the exception of
serum calcium, both iPTH and serum phosphorus were significantly associated
with occurrence of CV events. iPTH levels had a direct association with CV
events with a mean iPTH of 157.34±106.95 pg/ml in patients with CV events
versus 108.98±85.63 pg/ml in patients without any CV event (P=0.0005). The mean
serum phosphorus for the group with CV event was 3.57±0.73 mg/dl which was
significantly higher than those without CV events (P=0.03).
Conclusion:
The current study indicated that serum
phosphorus and intact iPTH levels were significantly associated with CV events
in patients with CKD.
Keywords: serum phosphorus, serum calcium, serum iPTH, cardiovascular events,
chronic kidney disease.
Objective:
To determine the association between serum
phosphorus, serum calcium, and serum iPTH and the occurrence of cardiovascular
events in patients with diagnosed chronic kidney disease.
Methodology:
A prospective cohort study was conducted at
Pir Abdul Qadir Shah Jeelani Institute Of Medical Sciences Gambat, Khairpur
Mirs and Jinnah Postgraduate Medical Centre between August 2019 and July 2020.
All patients over 18 years of age were eligible to participate in the study.
Patients with incomplete data or those who were lost to follow-up were excluded
from the study. Mineral metabolism parameters including, serum calcium,
Phosphorus, and intact iPTH (iPTH), levels were recorded for all patients.
Patients were followed up till the start of August 2020 to record any
cardiovascular event. Patients were sub stratified into two groups i.e. with or
without a CV event.
Results:
The study reported that with the exception of
serum calcium, both iPTH and serum phosphorus were significantly associated
with occurrence of CV events. iPTH levels had a direct association with CV
events with a mean iPTH of 157.34±106.95 pg/ml in patients with CV events
versus 108.98±85.63 pg/ml in patients without any CV event (P=0.0005). The mean
serum phosphorus for the group with CV event was 3.57±0.73 mg/dl which was
significantly higher than those without CV events (P=0.03).
Conclusion:
The current study indicated that serum
phosphorus and intact iPTH levels were significantly associated with CV events
in patients with CKD.
Keywords: serum phosphorus, serum calcium, serum iPTH, cardiovascular events,
chronic kidney disease.